Kiniksa Pharmaceuticals Ltd. 宣布其研发药物KPL-387的二期临床试验数据预计在2026年下半年公布。此外,公司计划在今年年底前启动该药物的三期临床试验。
Kiniksa Pharmaceuticals Ltd. 宣布其研发药物KPL-387的二期临床试验数据预计在2026年下半年公布。此外,公司计划在今年年底前启动该药物的三期临床试验。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.